COMPARE · Data as of August 21, 2026
ADUS vs DVA
Verdict: Side-by-side breakdown using the Bull Rankings model. ADUS scored 74.8, DVA scored 68.9 — ADUS leads.
Compare another set
ADUS
Addus HomeCare Corporation
74.8
$120.81 · $2.3B
fundamentals as of
Score gap
5.9
ADUS leads
DVA
DaVita Inc.
68.9
$173.82 · $11.1B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestDVA14.7x
- Fastest growthADUS+15.9%
- Highest qualityDVA69 / 100
- Largest discount to fair valueDVA-67%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
ADUS
stronger →← stronger
DVA
59
Qualityreturns · margins · balance sheet
69
90
Growthrevenue & earnings expansion
68
79
Valuevaluation vs sector peers
70
ADUS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
ADUS
DVA
$155mC
FCF
$1.6bC+
+15.9%B+
Rev
+6.4%C+
0.09B+
D/E
—
21.2xB+
P/E
14.7xA-
1.10B+
PEG
0.55A-
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
ADUS
DVA
19% below
Price vs fair valuelower is cheaper
67% below
~0%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-17%/yr
+17%
1-yr DCF upside
+165%
+23%
5-yr DCF upside
+207%
+32%
10-yr DCF upside
+282%
These two disagree on this pair: the Value pillar ranks cheapness against sector peers, while price-vs-fair-value is an absolute read. A name can be the better value in its sector and still the dearer one on cash flows.
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
ADUS
No notable signals flagged.
DVA
Why this score
- Buying back stock
- Durable high returns
The companies
ADUSAddus HomeCare Corporation
Why now
Medical Care Facilities · market cap $2.3b. Trading near 52-week high of $124.44 — momentum setup, limited technical margin of safety. Revenue growing +16%, comfortably above the S&P median. 13 sell-side analysts rate this a Buy with a mean 1-yr target of $134.69 (implying +11% upside).
Moat
FCF converts 147% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trading within 3% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction.
DVADaVita Inc.
Why now
Medical Care Facilities · market cap $11.1b. Down 30% from 52-week high of $247.49 — deep drawdown territory. PEG 0.55 — paying under fair value for the growth rate. 7 sell-side analysts rate this a Buy with a mean 1-yr target of $218.43 (implying +26% upside).
Moat
FCF converts 136% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
ROE -154% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where ADUS and DVA diverge
On the headline score the gap is 5.9 points in favor of ADUS. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- GrowthADUS 89.5 · DVA 67.8ADUS +21.7
- QualityADUS 59.0 · DVA 68.9DVA +9.9
- ValueADUS 79.2 · DVA 69.9ADUS +9.3
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.